Literature DB >> 29190349

Identification and characterization of the Streptococcus pneumoniae type 3 capsule-specific glycoside hydrolase of Paenibacillus species 32352.

Dustin R Middleton1,2,3, Xing Zhang4, Paeton L Wantuch1,2,3, Ahmet Ozdilek1,2,3, Xinyue Liu4, Rachel LoPilato1, Nikhil Gangasani1, Robert Bridger1,3, Lance Wells1,3, Robert J Linhardt4, Fikri Y Avci1,2,3.   

Abstract

Bacillus circulans Jordan 32352 was isolated from decaying organic matter in the New Jersey soil in the early 1930s. This soil-dwelling bacterium produced an enzyme capable of degrading the type 3 capsular polysaccharide (Pn3P) of Streptococcus pneumoniae (Spn). Early reports of this enzyme, Pn3Pase, demonstrated its inducibility by, and specificity for Pn3P. We set out to identify and clone this enzyme for its recombinant expression and characterization. We first sequenced the genome of this bacterial species, and reclassified the Pn3Pase producing bacterium as Paenibacillus species 32352. We identified the putative protein of Pn3Pase through mass spectrometry-based proteomics and cloned the gene for recombinant expression. We then characterized the oligosaccharide products generated upon the enzymatic depolymerization of Pn3P. Sequence analysis suggests that this glycoside hydrolase belongs to a new carbohydrate-active enzyme GH family. To our knowledge, this is the only enzyme to demonstrate Pn3P depolymerization activity.
© The Author(s) 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Paenibacillus; capsular polysaccharide; enzyme processing; glycoside hydrolase

Mesh:

Substances:

Year:  2018        PMID: 29190349      PMCID: PMC6192388          DOI: 10.1093/glycob/cwx097

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  43 in total

1.  GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes.

Authors:  A J Walhout; G F Temple; M A Brasch; J L Hartley; M A Lorson; S van den Heuvel; M Vidal
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  2-(2'-Hydroxyphenyl)benzene sulfinate desulfinase from the thermophilic desulfurizing bacterium Paenibacillus sp. strain A11-2: purification and characterization.

Authors:  J Konishi; K Maruhashi
Journal:  Appl Microbiol Biotechnol       Date:  2003-05-13       Impact factor: 4.813

3.  Studies of anti-pneumococcal serum; complement-fixing activity of fractionated rabbit serum.

Authors:  C E RICE; G R SICKLES
Journal:  J Immunol       Date:  1946-11       Impact factor: 5.422

4.  THE SPECIFIC ACTION OF A BACTERIAL ENZYME ON PNEUMOCOCCI OF TYPE III.

Authors:  O T Avery; R Dubos
Journal:  Science       Date:  1930-08-08       Impact factor: 47.728

5.  Production of specific pneumococcus carbohydrate-splitting enzymes in media to which the specific substrate was not added.

Authors:  M SHAW; G M SICKLES
Journal:  J Immunol       Date:  1950-01       Impact factor: 5.422

6.  Requirement for capsule in colonization by Streptococcus pneumoniae.

Authors:  A D Magee; J Yother
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance.

Authors:  Aaron L Nelson; Aoife M Roche; Jane M Gould; Kannie Chim; Adam J Ratner; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

8.  First report of Paenibacillus cineris from a patient with cystic fibrosis.

Authors:  Robson Souza Leão; Rosana Helena Vicente Pereira; Alex Guerra Ferreira; Adma Nascimento Lima; Rodolpho Mattos Albano; Elizabeth Andrade Marques
Journal:  Diagn Microbiol Infect Dis       Date:  2009-08-25       Impact factor: 2.803

9.  dbCAN: a web resource for automated carbohydrate-active enzyme annotation.

Authors:  Yanbin Yin; Xizeng Mao; Jincai Yang; Xin Chen; Fenglou Mao; Ying Xu
Journal:  Nucleic Acids Res       Date:  2012-05-29       Impact factor: 16.971

10.  The First Paenibacillus larvae Bacteriophage Endolysin (PlyPl23) with High Potential to Control American Foulbrood.

Authors:  Ana Oliveira; Marta Leite; Leon D Kluskens; Sílvio B Santos; Luís D R Melo; Joana Azeredo
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

View more
  7 in total

1.  Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens.

Authors:  Amy V Paschall; Dustin R Middleton; Fikri Y Avci
Journal:  J Vis Exp       Date:  2019-04-05       Impact factor: 1.355

Review 2.  Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine Targets.

Authors:  Javid Aceil; Fikri Y Avci
Journal:  Front Cell Infect Microbiol       Date:  2022-05-12       Impact factor: 6.073

3.  Invasive pneumococcal disease in relation to vaccine type serotypes.

Authors:  Paeton L Wantuch; Fikri Y Avci
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

Review 4.  Bacterial biopolymers: from pathogenesis to advanced materials.

Authors:  M Fata Moradali; Bernd H A Rehm
Journal:  Nat Rev Microbiol       Date:  2020-01-28       Impact factor: 60.633

5.  Enzymatic Hydrolysis of Pneumococcal Capsular Polysaccharide Renders the Bacterium Vulnerable to Host Defense.

Authors:  Dustin R Middleton; Amy V Paschall; Jeremy A Duke; Fikri Y Avci
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

6.  Characterization of the β-glucuronidase Pn3Pase as the founding member of glycoside hydrolase family GH169.

Authors:  Paeton L Wantuch; Satya Jella; Jeremy A Duke; Jarrod J Mousa; Bernard Henrissat; John Glushka; Fikri Y Avci
Journal:  Glycobiology       Date:  2021-04-01       Impact factor: 4.313

7.  A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies.

Authors:  Ahmet Ozdilek; Jiachen Huang; Rachelle Babb; Amy V Paschall; Dustin R Middleton; Jeremy A Duke; Liise-Anne Pirofski; Jarrod J Mousa; Fikri Y Avci
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.